250 related articles for article (PubMed ID: 24424706)
1. A meta-analysis of inositol for depression and anxiety disorders.
Mukai T; Kishi T; Matsuda Y; Iwata N
Hum Psychopharmacol; 2014 Jan; 29(1):55-63. PubMed ID: 24424706
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
3. Myo-inositol has no beneficial effect on premenstrual dysphoric disorder.
Nemets B; Talesnick B; Belmaker RH; Levine J
World J Biol Psychiatry; 2002 Jul; 3(3):147-9. PubMed ID: 12478879
[TBL] [Abstract][Full Text] [Related]
4. Controlled trials of inositol in psychiatry.
Levine J
Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302
[TBL] [Abstract][Full Text] [Related]
5. Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Parikh SV; LeBlanc SR; Ovanessian MM
Can J Psychiatry; 2010 Mar; 55(3):136-43. PubMed ID: 20370963
[TBL] [Abstract][Full Text] [Related]
6. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis.
Fernandes BS; Dean OM; Dodd S; Malhi GS; Berk M
J Clin Psychiatry; 2016 Apr; 77(4):e457-66. PubMed ID: 27137430
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
8. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials.
Borges-Vieira JG; Cardoso CKS
Nutr Neurosci; 2023 Mar; 26(3):187-207. PubMed ID: 35156551
[TBL] [Abstract][Full Text] [Related]
10. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
Bech P; Lönn SL; Overø KF
J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
[TBL] [Abstract][Full Text] [Related]
11. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders.
Slotema CW; Blom JD; Hoek HW; Sommer IE
J Clin Psychiatry; 2010 Jul; 71(7):873-84. PubMed ID: 20361902
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials.
Faridhosseini F; Sadeghi R; Farid L; Pourgholami M
Hum Psychopharmacol; 2014 May; 29(3):216-23. PubMed ID: 24911574
[TBL] [Abstract][Full Text] [Related]
13. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
Papakostas GI; Martinson MA; Fava M; Iovieno N
J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.
Offidani E; Guidi J; Tomba E; Fava GA
Psychother Psychosom; 2013; 82(6):355-62. PubMed ID: 24061211
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and network meta-analysis of carbon dioxide provocation in psychiatric disorders.
Tural U; Iosifescu DV
J Psychiatr Res; 2021 Nov; 143():508-515. PubMed ID: 33250190
[TBL] [Abstract][Full Text] [Related]
16. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?
Roshanaei-Moghaddam B; Pauly MC; Atkins DC; Baldwin SA; Stein MB; Roy-Byrne P
Depress Anxiety; 2011 Jul; 28(7):560-7. PubMed ID: 21608087
[TBL] [Abstract][Full Text] [Related]
17. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
18. Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Yonkers KA
J Clin Psychiatry; 1997; 58 Suppl 3():62-7; discussion 68-9. PubMed ID: 9133494
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, controlled trial of inositol treatment of depression.
Levine J; Barak Y; Gonzalves M; Szor H; Elizur A; Kofman O; Belmaker RH
Am J Psychiatry; 1995 May; 152(5):792-4. PubMed ID: 7726322
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
